Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
about
The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in TumorsThe crystal structure of a mammalian fatty acid synthaseStructure and function of an iterative polyketide synthase thioesterase domain catalyzing Claisen cyclization in aflatoxin biosynthesisCrystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo- -linolenic acidCrystal structure of the human fatty acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibitionMycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatinTetrahydrolipstatin inhibition, functional analyses, and three-dimensional structure of a lipase essential for mycobacterial viabilityKeys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding PocketsMechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase.A concise, phosphate-mediated approach to the total synthesis of (-)-tetrahydrolipstatin.Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.Combining cross-metathesis and activity-based protein profiling: new β-lactone motifs for targeting serine hydrolasesImmunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay.Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthaseHow lipidomics provides new insight into drug discovery.The metabolic serine hydrolases and their functions in mammalian physiology and disease.Fatty acid synthase as a potential therapeutic target in cancer.Crystal Structure and Substrate Specificity of Human Thioesterase 2: INSIGHTS INTO THE MOLECULAR BASIS FOR THE MODULATION OF FATTY ACID SYNTHASEEstimation of Hydrogen-Exchange Protection Factors from MD Simulation Based on Amide Hydrogen Bonding Analysis.Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.Polyketide Ring Expansion Mediated by a Thioesterase, Chain Elongation and Cyclization Domain, in Azinomycin Biosynthesis: Characterization of AziB and AziG.Quantitation of fatty acyl-coenzyme As in mammalian cells by liquid chromatography-electrospray ionization tandem mass spectrometryDevelopment of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines.In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy.Fatty acid synthase inhibitors: new directions for oncology.Targeting lipid esterases in mycobacteria grown under different physiological conditions using activity-based profiling with tetrahydrolipstatin (THL).Current understanding of fatty acid biosynthesis and the acyl carrier protein.Structure and function of eukaryotic fatty acid synthases.Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs.Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering.Synthesis of novel beta-lactone inhibitors of fatty acid synthase.Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors.Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.Inhibition of the thioesterase activity of human fatty acid synthase by 1,4- and 9,10-diones.Analysis of the Sequences, Structures, and Functions of Product-Releasing Enzyme Domains in Fungal Polyketide Synthases.
P2860
Q26996477-F278B075-7E19-4255-9DBE-F9936C34D45CQ27651988-477232EB-D057-49C3-BDE5-120B09EFCF21Q27660310-6CE1D635-780A-4B03-A83A-6A0EFB3A8333Q27673705-D0B31DAE-E2D9-4761-9EAC-B0EF77CDCC02Q28383149-005C0E06-B281-444E-AFAE-946CDB8003ADQ28474588-8FCD4634-F4FF-419C-898C-E7BC1805FCCAQ28487544-367D4FE4-D8FD-4144-AECF-D30D07887379Q28548681-C46387E9-2CB9-4CE2-ADA2-FF94C8DA0406Q30589786-8F201458-2DE8-4301-A06D-672B9D798016Q33922563-1AE3A260-BF37-414C-ACCD-8149EE2D0C9CQ34058540-65CCC10D-1EFF-4CE2-9B6C-2208996A5AD3Q34279501-F699927B-A249-410F-AB7C-66CE26B6B127Q34785627-14964737-0991-4EA9-AF0D-785A05F47379Q34995628-7D6FAC46-3779-409D-884D-3A504E013242Q35013508-4672267A-D66F-4463-B5D1-FC2DDF953D85Q35167171-71F4ECC2-DECA-4737-B407-AEC6888344E9Q35333042-540FDD16-569E-407A-9C12-84327D35F022Q35401716-FD4D175F-4E67-442D-B579-535EE06A6251Q35867872-D50CF3A2-E2ED-4076-AB28-2161AA5557EEQ36103720-1440ADE5-A4E6-407D-A85A-E0443EFF2F30Q36124825-138BFC2D-107D-4B2C-AE74-128863BBEF20Q36290627-0C8D08D4-F014-418A-BC0D-D00B86B94DC3Q36435773-15C2A7AB-C855-4C1B-81CE-74AB85201C28Q36535452-4DC8957A-5F13-4FB3-BC6B-17E28578CEDEQ36558390-74092EF7-EDE5-4C6F-97B0-283819D8A3A3Q36664997-28A4601A-928A-4F0D-BCAC-A17FC0A6C1A5Q36926246-1D84C8E3-DCD3-4D1B-818E-04311D2F0910Q36985879-0F928A1B-8F9E-45E1-A4D5-C475ABEA164CQ37563877-95A5576E-CE4A-400B-B8DF-67D9F17350BAQ37775996-AF6ADFF3-4354-40D7-9F13-3F0838218141Q37781847-8B95DF50-521E-45BF-AAA6-6EF50E75ACB9Q38019608-E443940F-276D-438B-A444-8BC8D560A43BQ38264138-C24C5DBF-FDF3-4229-911C-B60CFDD7F3CAQ38392343-BB8C42AE-D5BC-4774-9653-C48B689B281EQ38722530-3D7CEEF9-0B83-4478-A5EE-533A91F9C1D3Q38966211-982C2AF2-076C-4872-BE22-2410DF01BEC3Q38972039-FFECA80C-BEF2-455C-8B62-14A4692413DCQ40688083-AA5011DE-D2F4-47A1-A713-BA8708357E05Q40961927-DD650D51-5061-46C8-8295-9471B4B88697Q41473688-28C26307-AB4F-4728-99A3-122921831C54
P2860
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@ast
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@en
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@nl
type
label
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@ast
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@en
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@nl
prefLabel
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@ast
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@en
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@nl
P2093
P2860
P356
P1476
Crystal structure of the thioe ...... synthase inhibited by Orlistat
@en
P2093
Charles W Pemble
Lynnette C Johnson
Steven J Kridel
W Todd Lowther
P2860
P2888
P356
10.1038/NSMB1265
P577
2007-08-01T00:00:00Z
P5875
P6179
1019966432